Jo Wallis
Jo Wallis is a senior commercialisation and market access specialist with over 25 years of experience in commercial & pricing strategy, HTA, reimbursement pathways, and launch preparation for pharma and biotech. Aligning scientific evidence, payer expectations, and commercial objectives to support efficient and sustainable access to new therapies across global, EU and UK markets.
Her expertise spans commercial & pricing strategy, reimbursement pathways, health technology assessment (HTA), evidence planning, commercial due diligence, and integrated access strategy development. She has held senior leadership roles in global life sciences organisations and specialist consultancies, leading teams responsible for market access, pricing governance, pipeline and portfolio planning, and strategic commercialisation programmes.